Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ebr

PUBLICATIONS

European Biopharmaceutical Review

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:
Advertising Helga Schweissguth	Editorial George Grant

Connect with us on Twitter: follow @EBRmagazine

Click here to view the digital version of EBR

	Click here to view the digital version of EBR BIO-Europe Supplement

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

Infectious Diseases

Infectious Diseases

The Future of Vaccines for Infectious Diseases

How we can make better use of the often-overlooked power of cytotoxic T cells using arenaviruses in the development of vaccines for infectious diseases.

Klaus Orlinger, Henning Lauterbach, Daniel Pinschewer, and Igor Matushansky at HOOKIPA Pharma

Rare Diseases

Pooling Efforts to Drive Gene Therapies for Rare Diseases

A three-pronged approach that will drive gene therapies to market in a more efficient and financially viable way, and then ultimately into the hands of patients. This requires improved collaboration across the biopharma industry.

Christian Schneider at Biopharma Excellence

AI in Drug Discovery

The Rise of Machine Learning and What it Means For Biological and Chemical Data

Despite advances, there is still one bottleneck holding back more significant developments in drug discovery. What are the problems, and how should they be addressed?

Nil Adell-Mill at Arctoris

Published quarterly in

January, April,
July, and October

News and Press Releases

ACG introduces Smart Connected Product to enable remote machine monitoring in real-time

Mumbai 12th January, 2022 - New solution improves machine efficiency, prevents breakdowns, lowers costs and reduces risks whilst providing anytime, anywhere remote monitoring. ACG, the world’s leading integrated solutions provider for pharmaceutical companies, has introduced the Smart Connected Product - a new, innovative, IIoT solution, that connects production machines at any facility and visualises relevant information on a single platform. This data can be viewed over the web on any device with a secure connection and is accessible only to authorised users.
More info >>

All releases >>

White Papers

Key to Outsourcing Method Development and Validation A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >>

All white papers >>